MK-8527

N/A

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameMK-8527
Drug Alias NameMK-8527
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNucleoside reverse transcriptase translocation inhibitor
TargetsNucleotide reverse transcriptase
Therapy Area/IndicationsRenal InsufficiencyHepatic InsufficiencyHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesVietnamUganda +[19
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme LLC
Inactive CompaniesN/A
Active IndicationsRenal InsufficiencyHepatic InsufficiencyHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A